Turning Point Therapeutics, Inc.
MACROCYCLIC KINASE INHIBITORS AND THEIR USE
Last updated:
Abstract:
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
Status:
Application
Type:
Utility
Filling date:
18 Dec 2018
Issue date:
25 Mar 2021